The Kansas City region is a global leader at the nexus of human and animal health, and BioNexus KC plays a central role in advancing that leadership. As a regional convener and catalyst for life sciences innovation, BioNexus KC is uniquely positioned to promote scientific advancement and strengthen the impact of the region’s research ecosystem.
BioNexus KC stimulates collaboration, accelerates the translation of emerging technologies from concept to real-world application, and creates opportunities at the intersection of:
– Human and Animal Health
– Urban and Rural Health
– Healthcare and Information Technology
– Academia and Industry
– Kansas and Missouri
Through strategic partnerships, data-driven initiatives, and support for regional innovation, BioNexus KC advances life sciences research that drives scientific progress and innovation.
BioNexus KC houses Digital Health KC and the KC BioHub and is a partner of RareKC. Together, these programs strengthen collaboration, support innovation, and help build a stronger life sciences and health innovation ecosystem across the Kansas City region.
Each initiative brings together leaders from across industry, academia, and healthcare to solve real-world challenges. By connecting people and resources, they help drive meaningful progress for the KC region.
The regional vision developed through the assessment process states, “The Kansas City region is a global leader at the nexus of human and animal health, benefiting all our citizens and the economy.” These nexus opportunities will be different for each strategic area. They will likely range from using naturally occurring cancer in dogs for accelerating human discoveries to advancing our strength in health IT and outcomes research.
Four areas of scientific strength were identified: animal health, cancer research and care, neuroscience, and health IT and outcomes research.
BioNexus KC has played a key role in advancing life sciences initiatives and milestones across the region, bringing organizations together through collaboration and innovation. The organization is proud to support this work across the ecosystem.

Subsequently, the Kansas City Area Life Sciences Institute (KCALSI) was created to develop a sustainable economic development advantage through successful implementation of the region’s life sciences plan. The plan identified several strategies from increasing life sciences research capacity, to commercializing products developed from the research, to attracting new life sciences companies to the region.

In 2000, KCALSI accepted the challenge of helping the region to become a nationally known center of established, world-class life sciences companies, private and academic research institutions, and emerging, entrepreneurial companies

The Kansas City Proteomics Consortium (KCPC) was created with a $1 million challenge grant from the Cray Foundation. The KCPC represented a collaboration between eight stakeholders, for whom KCALSI secured $12.3 million in federal funds and donor grants to equip these stakeholders’ laboratories significantly expanding regional proteomics capabilities and capacity.

The Kansas City Area Life Sciences Institute Association renamed to Kansas City Area Life Sciences Institute 501(C)(3) and operations launched. KCALSI was initially supported by 8 stakeholders:

The Institutional Advisory Committee (IAC) was formed to provide technical, scientific input regarding regional research initiatives to advise the KCALSI Board of Directors. The IAC also served as a critical communication channel between KCALSI and the stakeholder institutions.

With the support of the Kansas City Area Development Council, KCALSI held its inaugural Annual Dinner at the Intercontinental Hotel. The initial speaker was Dr. Webster Cavenee Ludwig Institute for Cancer Research, San Diego, and KCALSI Scientific Advisory Committee member.

The University of Missouri and Kansas State University are added as stakeholders.

The Kansas City Science initiative (KCSI), a program utilizing research-based, hands-on, inquiry-based curricula combined with teacher professional development, to enhance STEM education for students from grades K- 8. Nicole Riegel, formerly manager of the Bayer “Making Science Make Sense” program, was hired to manage the KCSI. The program spun out as SySTEMic Innovations in 2010.

KCALSI engaged Richard Seline from New Economy Strategies to assess the region’s life sciences and technology assets This data-driven process tracked every federal research dollar supporting life sciences research to identify research strengths. Six “Hot Teams,” comprised of academic, business, and civic leaders were formed to develop business plans for the following scientific areas:
1. Animal Health
2. Bio-Pharma Drug Discovery
3. Cardiovascular/Tissue Engineering
4. Neurosciences
5. Oncology
6. Personalized Medicine/Health Care

The 2005 Strategic Assessment identified a regional strength in animal health. With an investment from Bayer Animal Health, the Kansas City Animal Health Corridor was formed. The KCAHC was a collaboration between KCALSI, Kansas City Area Development Corporation, and the Greater Kansas City Chamber of Commerce.

The EDA funded the Regional Life Sciences Incubator assessment to determine the best location for a regional incubator. Determining the appropriate location for the development of a wet lab incubator was a key addition for growing and diversifying the region’s life sciences cluster. The funded study assessed the feasibility, site selection, and optimal characteristics of a wet laboratory incubator to support biotechnology company incubation and recruitment. Based on the results of the study, KUMC obtained a second EDA grant to convert the Briedenthal building to a wet lab incubator currently known as the KUMC Business & Technology Business Center.

The Animal Health Corridor established with Kansas City Area Development Council (KCADC) and Greater Kansas City Chamber of Commerce (GKCCC).

KCALSI identified In 2006 the NBAF opportunity and formed regional partnerships charged with developing expressions of interest to the Department of Homeland Security (DHS). KCALSI coordinated the submission of regional proposals – one focused on Leavenworth and the other on Manhattan.

The Department of Homeland Security announces National Bio-Agro Defense Facility to be built in Manhattan, KS.

Wayne O. Carter, DVM, PhD, DACVIM hired as President of Kansas City Area Life Sciences Institute.

KCALSI Strategic Assessment completed, "Path to 2025".

First Midwest Bioinformatics Conference.

Collaborate2Cure Launched.

KCALSI Renamed BioNexus KC.





BioNexus KC is a 501(c)(3) not-for-profit organization governed by its President, the Board of Directors and the Board’s four permanent committees.